Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
BioCardia, Inc. (BCDA) had Stock-Based Compensation of $0.17M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.71M |
|
-- |
|
-- |
|
$2.73M |
|
$-2.73M |
|
-- |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.73M |
|
$-2.71M |
|
4.64M |
|
4.64M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$1.17M |
|
$0.02M |
|
$0.99M |
|
$2.17M |
|
$3.23M |
|
-- |
|
$0.45M |
|
$3.69M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
4.68M |
|
| Cash Flow Statement Financials | |
$-1.62M |
|
-- |
|
$0.20M |
|
$2.37M |
|
$0.95M |
|
$-1.42M |
|
|
Stock-Based Compensation |
$0.17M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
178.42% |
|
178.42% |
|
-125.21% |
|
178.42% |
|
$-0.32 |
|
$-0.35 |
|
$-0.35 |
|